A leiomyosarcoma is a rare cancerous tumor of the smooth muscle cells. It is most often found in the uterus or abdomen.
William Tap is a Hematologist Oncology expert in New York, New York. Tap has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in the treatment of Leiomyosarcoma. He is also highly rated in 35 other conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Epithelioid Sarcoma, Tissue Biopsy, and Liver Embolization. He is licensed to treat patients in California and New York. Tap is currently accepting new patients.
Brian Van Tine is an Oncologist in Saint Louis, Missouri. Van Tine has been practicing medicine for over 17 years and is rated as an Elite expert by MediFind in the treatment of Leiomyosarcoma. He is also highly rated in 37 other conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Synovial Sarcoma, Epithelioid Sarcoma, and Liposarcoma. He is licensed to treat patients in Missouri. Van Tine is currently accepting new patients.
Martee Hensley is an Oncologist in New York, New York. Hensley has been practicing medicine for over 33 years and is rated as an Elite expert by MediFind in the treatment of Leiomyosarcoma. She is also highly rated in 18 other conditions, according to our data. Her top areas of expertise are Leiomyosarcoma, Endometrial Cancer, Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, and Salpingo-Oophorectomy. She is licensed to treat patients in New York. Hensley is currently accepting new patients.
Summary: Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating cancer cell/macrophage hybrid cells in the peripheral blood and the evolution of this rate over time. The study will be conducted on a population of patients with leiomyosarcoma and treated in the context of routine care. 20 patients will be included: 10 patients with localized disease. 10 patients with...
Summary: This study is a single-center, prospective, one-arm clinical study, which is planned to be carried out in Cancer Hospital of Chinese Academy of Medical Sciences. The patients with locally advanced or metastatic leiomyosarcoma who are inoperable are enrolled, aiming at the effectiveness and safety of temozolomide for injection combined with epirubicin as the first-line treatment for advanced leiomy...
Published Date: January 25, 2022
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Goldblum JR, Folpe AL, Weiss SW. Leiomyosarcoma. In: Goldblum JR, Folpe AL, Weiss SW, eds. Enzinger and Weiss's Soft Tissue Tumors. 7th ed. Philadelphia, PA: Elsevier; 2020:chap 16.
National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology (NCCN guidelines): soft tissue sarcoma. Version 2.2022. www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Updated May 17, 2022. Accessed June 9, 2022.